Portal de Periódicos da CAPES

Letter to the editor: Spurious protein C deficiency due to antiphospholipid antibodies

1991; Wiley; Volume: 36; Issue: 4 Linguagem: Inglês

10.1002/ajh.2830360418

1096-8652

Paolo Simioni, Annarosa Lazzaro, S. Zanardi, Antonio Girolami,

Blood disorders and treatments

American Journal of HematologyVolume 36, Issue 4 p. 299-300 Letter to the EditorFree Access Letter to the editor: Spurious protein C deficiency due to antiphospholipid antibodies Paolo Simioni, Paolo Simioni University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorAnnarosa Lazzaro, Annarosa Lazzaro University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorSandra Zanardi, Sandra Zanardi University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorAntonio Girolami, Antonio Girolami University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this author Paolo Simioni, Paolo Simioni University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorAnnarosa Lazzaro, Annarosa Lazzaro University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorSandra Zanardi, Sandra Zanardi University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this authorAntonio Girolami, Antonio Girolami University of Padua Medical School Institute of Medical Semeiotics Second Chair of Medicine Padua, ItalySearch for more papers by this author First published: April 1991 https://doi.org/10.1002/ajh.2830360418Citations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Haire WD, Newland JR: Protein C deficiency and anticardiolipin antibodies in a family with a premature stroke. Am J Hematol 33: 61–63, 1990. 10.1002/ajh.2830330112 PubMedWeb of Science®Google Scholar 2 Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth–Young CG, Loizou S, Hughes GRV: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2: 1088, 1983. Google Scholar 3 Harris EN, Gharavi AE, Hedge U, Derue G, Morgan SH, Englert H, Chan JK, Asherson RA, Hughes GRV: Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59: 231, 1985. 10.1111/j.1365-2141.1985.tb02989.x PubMedWeb of Science®Google Scholar 4 Fort JG, Cowchock FS, Abruzzo JL, Smith JB: Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 30: 752, 1987. 10.1002/art.1780300705 CASPubMedWeb of Science®Google Scholar 5 Manoussakis MN, Tzioufas AG, Silis MP, Pange JE, Goudevenos J, Motsopoulos: High prevalence of anti–cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 69: 557, 1987. PubMedWeb of Science®Google Scholar 6 Jacobson DM, Jessica HL, Bontempo FA, Spero JA, Ragni MV, Reinmuth OM: Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions. Stroke 17: 1, 1986. 10.1161/01.STR.17.1.98 PubMedWeb of Science®Google Scholar 7 Girolami A, Cappellato MG, Lazzaro AR, Simioni P, Boscaro M: The report of an italian family with heterozygous protein C deficiency. Folia Haematol 115: 859–868, 1988. CASPubMedGoogle Scholar 8 Martinoli JL, Stocker K: Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 43: 253–264, 1986. 10.1016/0049-3848(86)90145-3 CASPubMedWeb of Science®Google Scholar 9 McNeil HP, Chesterman CN, Krilis SA: Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73: 506–513, 1989. 10.1111/j.1365-2141.1989.tb00289.x CASPubMedWeb of Science®Google Scholar 10 Exner T, McRea J: Studies on the relationship between "antiphospholipid" antibodies and the lupus anticoagulant. Blood Coagulation Fibrinolysis 1: 17–21, 1990. 10.1097/00001721-199003000-00004 CASPubMedGoogle Scholar 11 Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN: Measurement of anti–cardiolipin antibodies by an enzyme–linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 62: 738–745, 1985. CASPubMedWeb of Science®Google Scholar 12 Israels SJ, Seshia SS: Childhood stroke associated with protein C or S deficiency. J Pediatr 111: 562–564, 1987. 10.1016/S0022-3476(87)80122-1 CASPubMedWeb of Science®Google Scholar Citing Literature Volume36, Issue4April 1991Pages 299-300 ReferencesRelatedInformation